What Intelligent Fingerprinting does

Intelligent Fingerprinting Ltd., founded in 2007 by Chemistry Professor David Russell at the University of East Anglia, develops and manufactures a non-invasive fingerprint sweat-based drug screening system for workplace safety applications. Its core technology is a lateral flow immunoassay using fluorescence-labelled antibodies that detects drug metabolites in sweat collected from all ten fingertips. The product consists of two components: a single-use, tamper-evident Drug Screening Cartridge and a portable Drug Screening Reader that displays negative or non-negative results within approximately ten minutes, with batch testing capability of six tests in roughly three minutes per test. The detection window is targeted at recent drug use (16-24 hours), explicitly optimized for fitness-for-duty assessments rather than lifestyle monitoring. The company holds ISO 9001:2015 and ISO 13485:2016 certifications and operates confirmatory testing through a UKAS-accredited laboratory partner (LGC) using LC-MS/MS.

The company is a wholly owned subsidiary of Intelligent Bio Solutions Inc. (NASDAQ: INBS) and is headquartered in Cambridge, United Kingdom, with an 11-50 employee base and a network of 18 distribution partners covering 24 countries across the UK, Europe, the Middle East and Africa, Asia Pacific, and the United States. Its revenue model combines one-time hardware sales of the Reader (£2,560 example price) with recurring consumable cartridge sales (£1,280 per 80 tests), supplemented by training services (£600 per session) and back-to-lab confirmation kits (~£312 per 4 non-negative events). Go-to-market is enterprise field sales targeting safety-critical industries — construction, transport and logistics, manufacturing, and mining — augmented by distribution partners including Spjotgard (Scandinavia) and SMARTOX (US forensic market). Named enterprise customers include Transport UK London Bus (4,400+ employees across 14 sites), Smurfit Westrock, A&F Sprinklers, Precision Stevedores, Bouygues Construction (12 UK project sites), and Barcaldine Regional Council (Australia). The company has an FDA 510(k) submission filed in December 2024 with U.S. market entry planned for 2025, and previously raised approximately $23 million in disclosed funding rounds between 2011 and 2020.

Name

Intelligent Fingerprinting

Legal name

Intelligent Fingerprinting Ltd.

Website

https://intelligentfingerprinting.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Intelligent Fingerprinting develops a non-invasive fingerprint sweat-based drug screening system (single-use cartridge plus portable Reader) that delivers results in under ten minutes for workplace safety testing across construction, transport, manufacturing, and mining in 24 countries.

Ownership category

akta.pro rank

Product category

Workplace Drug Screening Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151), Investigation and Personal Background Check Services (561611)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)

akta.pro secondary industries

Drug & Alcohol Testing Coordination (BPACALAE), Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

Keywords

• Workplace drug testing
• Fingerprint sweat analysis
• Lateral flow immunoassay
• Safety-critical screening
• Point-of-care diagnostics

Headquarters

HQ city

Norwich

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Drug Screening Hardware: Sale of the Intelligent Fingerprinting Drug Screening Reader - a one-time capital investment that acts as an impartial official for testing. Includes hard carry case.
2. Drug Screening Consumables: Sale of single-use Drug Screening Cartridges for each test. Cartridges have a two-year shelf life from date of manufacture.
3. Training Services: Comprehensive training in application and collection of specimens, with virtual and in-person options available. Training and certification allows nominated personnel to administer sweat drug screening.
4. Laboratory Confirmation Services: Back-to-lab confirmation service using Fingerprint Collection Kit for Laboratory Analysis. Samples sent to independent UKAS-accredited laboratory for confirmatory analysis using liquid chromatography-mass spectrometry.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

Intelligent Fingerprinting designs, manufactures, and sells a non-invasive fingerprint sweat-based drug screening system for workplace use. The two-part product consists of single-use Drug Screening Cartridges and a portable Drug Screening Reader that uses fluorescence-labelled antibody lateral flow immunoassay to detect drug metabolites (opiates, methamphetamine, cocaine, THC, etc.) within a 16-24 hour window, delivering on-screen results in approximately 10 minutes. A back-to-lab Fingerprint Collection Kit enables UKAS-accredited LC-MS/MS confirmation when non-negative results require legal defence.

Product overview

Intelligent Fingerprinting offers a fingerprint sweat-based drug screening system consisting of two core products: the single-use Drug Screening Cartridge (lateral flow immunoassay with fluorescence detection) and the portable Drug Screening Reader. These work together to collect fingertip sweat samples and deliver negative/non-negative screening results in approximately 10 minutes. An add-on Fingerprint Collection Kit for Laboratory Analysis enables confirmatory testing via liquid chromatography-mass spectrometry at UKAS-accredited laboratories when non-negative results require confirmation. The company also offers Breath Alcohol Testing as a complementary product. The detection window focuses on recent drug use (16-24 hours), supporting fitness-for-duty decisions rather than lifestyle monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• Intelligent Fingerprinting Drug Screening Cartridge Single-use, tamper-evident cartridge that collects sweat from all ten fingertips using lateral flow immunoassay with fluorescence-labelled antibodies. Detects drug use including opiates, methamphetamine, cocaine, cannabis (THC), and more within a 16-24 hour detection window. Sold as a consumable with a two-year shelf life for workplace drug screening in safety-critical industries.
• Intelligent Fingerprinting Drug Screening Reader Portable fluorescence measurement instrument that reads the Drug Screening Cartridge and displays negative or non-negative screening results on screen within approximately 10 minutes. Supports batch testing of six individuals concurrently, reducing time per test to about three minutes. Multilingual interface supports English, Arabic, and Latin American Spanish. Sold as a one-time capital purchase (example price £2,560 including hard carry case).
• Fingerprint Collection Kit for Laboratory Analysis End-to-end confirmatory analysis kit used when a non-negative screening result requires laboratory confirmation. Includes tamper-evident collection materials, chain-of-custody documentation, and secure packaging for transport to a UKAS-accredited laboratory partner (LGC) where samples are analysed using liquid chromatography-mass spectrometry (LC-MS/MS) for legally defensible confirmation results.
• Breath Alcohol Testing Breath alcohol testing solution offered as a complementary product to the fingerprint drug screening system, providing enterprises with a comprehensive workplace substance testing offering for safety-critical environments.
• Training and Certification Services Comprehensive training in the application and collection of fingerprint sweat specimens, available as virtual or in-person options. Certification allows nominated customer personnel to administer sweat drug screening on site, delivered as a paid professional service.

Quantifiable outcome

• Testing 100% of workforce (160 tests) in under 90 minutes
• +5 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered flagship enterprise customer, key regional partner, key us market partner, core service partner and key customer case study.

• Bouygues Constructionflagship enterprise customerChannel Partner/ Reseller/ Distributor · 1 April 2026Global construction leader adopting fingerprint drug testing across UK operations. Employs approximately 35,600 people across more than 50 countries with €10.3 billion in sales in 2024. UK rollout begins with 12 project sites. Partnership marks important step toward safer, more efficient workplace practices in large, complex construction environments.
• Spjotgardkey regional partnerChannel Partner/ Reseller/ Distributor · 1 January 2021Regional distributor for Scandinavia (Sweden, Norway, Denmark) with increasing interest from Finland. Founded in 2021 by team with deep pharmaceutical expertise. Has positioned Intelligent Fingerprinting Drug Testing Solution as its flagship workplace drug testing solution. Expanding reach by partnering with complementary service providers including alcohol testing and drug-detection dog services.
• SMARTOXkey us market partnerChannel Partner/ Reseller/ DistributorUS-based provider of drug and alcohol testing products and services founded in 2012. Offers comprehensive portfolio for healthcare, justice, corporate, and education settings. Provides fully integrated services encompassing design, customer service, and administrative support. Distribution partner for US Forensic Use Only market.
• LGC (Laboratory)core service partnerStrategic or Co-development PartnerUKAS-approved laboratory partner providing confirmatory analysis using liquid chromatography-mass spectrometry. Enables identification and quantification of specific drugs with high degree of accuracy for legally defensible confirmation results.
• Barcaldine Regional Councilkey customer case studyOthersRemote Queensland local government that completed 160 non-invasive tests in under 90 minutes testing 100% of workforce. Following initial test, council personnel trained to conduct random testing in-house through Company's on-site testing model.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Quest Diagnostics: Quest Diagnostics operates one of the largest workplace drug testing laboratory networks in the US. Incumbent employer-services provider whose traditional urine-based lab offering Intelligent Fingerprinting competes against; less specialized but dominant in market share and procurement relationships.
• Laboratory Corporation of America (LabCorp): LabCorp provides workplace drug testing services through its Diagnostics Laboratory segment. Broad incumbent serving similar employer and occupational health customers with established urine, oral fluid, and hair testing workflows that Intelligent Fingerprinting positions as legacy alternatives.
• Abbott Toxicology (Alere): Abbott (via the Alere acquisition) operates a broad toxicology and POCT diagnostics portfolio including workplace drug testing solutions. Large established player with overlapping capabilities but focused across multiple diagnostic categories rather than specializing in sweat-based workplace testing.
• Eurofins Scientific: Eurofins operates toxicology laboratory services for workplace, forensic, and pharmaceutical drug testing globally. Comparable as a confirmation-testing laboratory partner alternative and as a broad toxicology incumbent whose LC-MS confirmation services compete with Intelligent Fingerprinting's LGC-partnered workflow.

Direct peers

• Premier Biotech: Premier Biotech manufactures oral fluid drug testing devices and services for workplace and criminal justice markets. Direct peer in rapid non-invasive drug screening with comparable POCT cartridge-plus-reader architecture.
• Securetec Detektions-Systeme: Securetec develops saliva-based rapid drug detection systems (DrugWipe) used by employers, law enforcement, and roadside testing. Direct peer offering non-invasive POCT drug screening with similar European market presence and workplace safety use cases.
• Psychemedics Corporation: Psychemedics provides hair-based drug testing for workplace and forensic applications. Directly comparable as an alternative-specimen (non-urine) drug testing provider targeting the same employer and criminal justice buyers as Intelligent Fingerprinting, though with longer detection window.
• OraSure Technologies: OraSure Technologies manufactures rapid oral fluid-based drug testing devices (Intercept) used in workplace and forensic settings. Directly comparable to Intelligent Fingerprinting as a non-invasive POCT drug-of-abuse testing provider serving similar safety-critical verticals with FDA-cleared products.

Regional players

• Cellmark Forensic Services: Cellmark is a UK-based forensic DNA and toxicology services provider serving criminal justice and coroners. Comparable to Intelligent Fingerprinting's UK forensic and confirmation lab services through LGC, with geographic overlap in UK forensic drug testing market.

Emerging players

• Drägerwerk: Drägerwerk manufactures the DrugCheck saliva-based rapid drug test and breath alcohol devices used in workplace safety. Comparable as a portable non-invasive drug/alcohol screening provider in industrial safety, with partial overlap on Intelligent Fingerprinting's transport and mining verticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@IntelligentFingerprinting
• LinkedInlinkedin.com/company/intelligent-fingerprinting-ltd
• Xx.com/ifingerprinting
• Facebookfacebook.com/intelligentfingerprinting

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds9 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelligent Fingerprinting